Clarus Therapeutics Holdings, Inc. (CRXT)
Market Closed
6 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 05
-0.02
-31.1594%
$
- Market Cap
- P/E Ratio
- Div Yield
2.74M Volume
- Eps
$ 0.07
Previous Close Want to track CRXT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Clarus Therapeutics Holdings, Inc. (CRXT) Statistics
Valuation metrics
Market Cap -
Enterprise value 15.85M
Trailing P/E (ttm) -0.02
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) -0.07
Enterprise Value/Revenue 1.14
Enterprise Value/EBITDA -0.64
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 0.01
52-Week high 7.14
Beta -
50-Day moving average -
200-Day moving average -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -4.05%
Operating margin -1.77%
Operational effectiveness
Return on assets -1.09%
Return on equity -4.63%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.58
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.35
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.1
Total debt (mrq) -
Total Debt/Equity (mrq) -2.66
Current ratio (mrq) 0.78%
Book value per share (mrq) -0.66
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
